Previous 10 | Next 10 |
- Strong double-digit top- and bottom-line growth across portfolio and geographies - Reaffirming 2019 guidance and 2020 financial targets - Pipeline execution: fedratinib, ozanimod and luspatercept regulatory applications submitted year-to-date - Acquisition by Bristol-Myers ...
In the past few days I received several notes thanking me for my November 1st article titled 10 Arbitrage Stocks to Buy as Market Wobbles . With the USG Corp ( USG ) merger now closed, that means all 10 of the deals I recommended have closed. At the time of the article at least half of the 10...
Image Source As risk-on returns to markets, we've seen the healthcare sector underperform significantly in recent months. While sectors like technology, communication, discretionary and others surge to new all-time highs, healthcare lags noticeably. However, many healthcare names have ...
Word came out just before the weekend ( first at Endpoints ) that GlaxoSmithKline (GSK) is laying off R&D employees at both Stevenage ((UK)) and Upper Providence ((US)). Current leadership is reorganizing drug discovery efforts to put more emphasis on oncology, immunology and genetic-lin...
Yes, it shrinks As you know, healthcare stocks and ETFs, such as the Health Care Select SPDR ETF ( XLV ), have gotten slammed following additional publicity given just a few days ago to Senator Bernie Sanders and his "Medicare for all" ((MFA)) program. Before the political season began this ...
Quick Take Cortexyme ( CRTX ) has filed to raise gross proceeds of $86.25 million from a U.S. IPO, according to an S-1 registration statement . The firm is developing a new potential therapeutic for the treatment of Alzheimer’s disease. CRTX has had positive safety trial results ...
Bristol-Myers Squibb Company (NYSE:BMY) (“Bristol-Myers Squibb) announced today the commencement, in connection with its previously announced acquisition of Celgene Corporation (NASDAQ:CELG) (“Celgene”) , of an exchange offer for any and all outstanding notes (the ...
Happy tax day and welcome to the latest edition of Merger Arbitrage Mondays. Merger activity increased last week with four new deals announced and two pending deals closing. We made a mistake last week when we indicated that the acquisition of Versum Materials (VSM) by Entegris (ENTG) closed...
As expected, Celgene ( CELG +0.8% ) shareholders have voted in favor of its merger with Bristol-Myers Squibb ( BMY +0.5% ). About 98% of the votes cast, representing over 70% of outstanding shares, backed the deal. More news on: Celgene Corporation, Bristol-Myers Squibb Company, Heal...
Celgene Corporation (NASDAQ: CELG) today announced that its stockholders have voted to approve the company’s proposed combination with Bristol-Myers Squibb Company (NYSE: BMY). Approximately 98% of the votes cast, and over 70% of the shares outstanding and entitled to vote, voted in f...
News, Short Squeeze, Breakout and More Instantly...
Celgene Corporation Company Name:
CELG Stock Symbol:
NASDAQ Market:
In this clip from "The Pharma & Biotech Show" on Motley Fool Live , recorded on Feb. 2 , Motley Fool contributor Brian Orelli analyzes Gilead 's (NASDAQ: GILD) earnings report and discusses why the biotech giant could see fairly low revenue growth or even see earnings dr...
What coronavirus? Amgen 's (NASDAQ: AMGN) latest set of quarterly figures, delivered Tuesday, showed growth in the company's fundamentals during a challenging time for companies across all economic sectors. The veteran biotech company booked revenue of nearly $6.21 billion in the second qu...
It's scary out there right now for investors, with wild market swings and a lot of negative news coming out of quarterly reports. There is one sector, however, that will survive and likely thrive despite the coronavirus pandemic shutdown -- healthcare. That said, investors shouldn't head for jus...